Loading clinical trials...
Loading clinical trials...
New Biomarkers of HBV Infection: Clinico-Biological Characterization and Impact on Infection Management
Conditions
Interventions
Collection of blood samples for the study of HBV biomarkers
Locations
1
France
Clinical Research Unit (CRU) Henri Mondor.
Créteil, Créteil, France
Start Date
November 28, 2023
Primary Completion Date
November 27, 2038
Completion Date
November 27, 2038
Last Updated
April 2, 2025
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions